(Q45356159)

13 December 2017

title

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease (English)

1 reference

13 December 2017

10

1 reference

13 December 2017

Sofia Berglund

5

0 references

Jens Gertow

object named as

Jens Gertow

2

0 references

Per Ljungman

8

object named as

Per Ljungman

1 reference

13 December 2017

Michael Uhlin

1

1 reference

13 December 2017

Mehmet Uzunel

3

1 reference

13 December 2017

Mantas Okas

4

1 reference

13 December 2017

Emma Watz

6

1 reference

13 December 2017

Mats Brune

7

1 reference

13 December 2017

Mark Maeurer

9

1 reference

13 December 2017

language of work or name

English

0 references

publication date

17 July 2012

1 reference

Clinical Infectious Diseases

13 December 2017

published in

1 reference

13 December 2017

volume

55

1 reference

13 December 2017

issue

8

1 reference

13 December 2017

page(s)

1064-1073

1 reference

The allogeneic graft-versus-cancer effect.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Nonmyeloablative allogeneic immunotherapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

A human memory T cell subset with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS625

21 January 2018

Identifiers

DOI

10.1093/CID/CIS625

1 reference

13 December 2017

1 reference